Superbug drug launched to fight growing threat of antibiotic resistance A new antibiotic designed to fight drug-resistant ‘superbugs’ has become available to patients in the UK.
Doctors are “running out of options” for treating common infections caused by bacteria which mutate to resist regular antibiotics, said microbiologist Matthew Dryden.
“Resistance is increasing, almost exponentially. It's a problem facing every emergency department in this country,” he told The Independent.
But innovative new drugs like Zavicefta, which combines a traditional antibiotic in the same class as penicillin with a brand new drug that attacks resistance mechanisms, are being introduced to tackle the growing threat of antibiotic resistance.
Doctors are “running out of options” for treating common infections caused by bacteria which mutate to resist regular antibiotics, said microbiologist Matthew Dryden.
“Resistance is increasing, almost exponentially. It's a problem facing every emergency department in this country,” he told The Independent.
But innovative new drugs like Zavicefta, which combines a traditional antibiotic in the same class as penicillin with a brand new drug that attacks resistance mechanisms, are being introduced to tackle the growing threat of antibiotic resistance.
No comments:
Post a Comment